NCT01012388已完成4 期
Post-Marketing Study of Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds in Persons of Color
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 5
- 主要终点
- Number Participants With Hypertropic Scarring, Keloid Formation, Hyper- or Hypopigmentation in Patients With Fitzpatrick Skin Types IV, V, and VI Receiving Nasolabial Fold Treatment
研究概览
简要总结
Post marketing study to assess the likelihood of hypertropic scarring, keloid formation and hyper- or hypopigmentation in patients with Fitzpatrick Skin Types IV, V, and VI receiving nasolabial fold treatment with Radiesse® Injectable Dermal Filler
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Is at least 18 years of age.
- •Has Fitzpatrick Skin Type IV, V, or VI.
- •Understands and accepts the obligation not to receive any other procedures or treatments in the nasolabial fold for 6 months.
排除标准
- •Has history of hyper- or hypo-pigmentation in the nasolabial folds, keloid formation, or hypertrophic scarring.
- •Has a known bleeding disorder or is receiving drug therapy that could increase the risk of bleeding.
- •Has nasolabial folds that are too severe to be corrected in one treatment session.
- •Has received any dermal filler or other injections, grafting or surgery in either nasolabial fold.
- •Is pregnant, lactating, or not using acceptable contraception.
结局指标
主要结局
Number Participants With Hypertropic Scarring, Keloid Formation, Hyper- or Hypopigmentation in Patients With Fitzpatrick Skin Types IV, V, and VI Receiving Nasolabial Fold Treatment
时间窗: 6 months
Skin type IV - Burns minimally, tans moderately and easily, Skin type V - Rarely burns, tans profusely; Skin type VI - Never burns, tans profusely
次要结局
未报告次要终点
研究者
研究点 (5)
Loading locations...
相似试验
已完成
4 期
Injectable Filler for Cheek FlatteningMalar DeficiencyNCT01225354DeNova Research20
已完成
不适用
Evaluation of Effectiveness and Safety of Radiesse (+) to Improve the Contour of Jawline by Adding Volume to the JawlineImprovement of Jawline ContourNCT03583359Merz North America, Inc.180
已完成
4 期
A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.Facial WrinklesNCT00293163Genzyme, a Sanofi Company120
已完成
不适用
Evaluation of Radiesse® Dermal Filler for Hand RejuvenationAging HandsNCT01004107Merz North America, Inc.101
已完成
不适用
Evaluation of Radiesse® Dermal Filler for Hand TreatmentAging HandsNCT01832090Merz North America, Inc.118